Positive allosteric modulation of AMPA receptors: A Novel potential antidepressant Therapy

Milestones in Drug Therapy

Volumn , Issue , 2010, Pages 39-56

  Nisenbaum, Eric S ^a   Witkin, Jeffrey M ^b  

^a ELI LILLY AND COMPANY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

6 QUINOXALINECARBOXYLIC ACID PIPERIDIDE; AMPA RECEPTOR; ANIRACETAM; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BRAIN DERIVED NEUROTROPHIC FACTOR; CITALOPRAM; CX 614; CYCLOTHIAZIDE; DULOXETINE; FLUOXETINE; IMIPRAMINE; LAMOTRIGINE; N [2 [4 (3 THIENYL)PHENYL]PROPYL] 2 PROPANESULFONAMIDE; N [2 [4 (4 CYANOPHENYL)PHENYL]PROPYL] 2 PROPANESULFONAMIDE; NISOXETINE; PIRACETAM; PSYCHOSTIMULANT AGENT; RILUZOLE; ROLIPRAM; UNCLASSIFIED DRUG;

BEHAVIOR CHANGE; BIPOLAR DISORDER; DRUG MECHANISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; DRUG TARGETING; ELECTROCONVULSIVE THERAPY; EXERCISE INTENSITY; GENE EXPRESSION REGULATION; HUMAN; MAJOR DEPRESSION; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; STRUCTURE ACTIVITY RELATION; UPREGULATION;

EID: 79953657342     PISSN: None     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-0346-0241-9_3     Document Type: Review

References (96)

1. Dubovsky SL, Buzan R (1999) Mood disorders. In: Hales RE, Yudofsky SC, Talbott JA (eds) Textbook of psychiatry, 3rd edn. American Psychiatric Press, Washington, DC, pp 479-565
2. Witkin JM, Li X (2009) New approaches to the management of major depressive disorder. In: Enna SJ, Williams M (eds) Contemporary aspects of biomedical research: biomedical issues. advances in pharmacology, vol 57. Academic, New York, pp 347-379
3. Skolnick P, Legutko B, Li X, Bymaster FP (2001) Current perspectives on the development of non-biogenic amine-based antidepressants. Pharmacol Res 43:411-443
4. Millan MJ (2004) The role of monamines in the actions of established and "novel" antidepressant agents: a critical review. Eur J Pharmacol 500:371-384
5. Iversen L (2005) The monoamine hypothesis of depression. In: Licinio J, Wong ML (eds) Biology of depression. Wiley-VCH, Weinheim, pp 71-86
6. Alt A, Nisenbaum ES, Bleakman D, Witkin JM (2006) A role for AMPA receptors in mood disorders. Biochem Pharmacol 71:1273-1288
7. Duman RS (2004) The neurochemistry of depressive disorders: preclinical studies. In: Charney DS, Nestler EJ (eds) Neurobiology of mental illness, 2nd edn. Oxford University Press, Oxford, pp 421-439
8. Skolnick P, Popik P, Trullas R (2010) N-Methyl-D-aspartate (NMDA) antagonists for the treatment of Depression. In: Skolnick P (ed) Glutamate-based therapies for psychiatric disorders. Springer, Basel
9. Schoepp DD, Skolnick P (2010) Introduction. In: Skolnick P (ed) Glutamate-based therapies for psychiatric disorders. Springer, Basel
10. Witkin JM (2010) Glutamatergic Modulators for the Treatment of Major Depressive Disorder: Metabotropic Glutamate Receptors. In: Skolnick P (ed) Glutamate-based therapies for psychiatric disorders. Springer, Basel
11. Bleakman D, Lodge D (1998) Neuropharmacology of AMPA and kainate receptors. Neuropharmacology 37:1187-1204
12. Dingledine R, Borges K, Bowie D, Traynelis SF (1999) The glutamate receptor ion channels. Pharmacol Rev 51:7-61
13. Hollmann M, Heinemann S (1994) Cloned glutamate receptors. Annu Rev Neurosci 17:31-108
14. Malenka RC, Nicoll RA (1999) Long-term potentiation - a decade of progress? Science 281:1870-1874
15. Lauterborn JC, Lynch G, Vanderklish P, Arai A, Gall CM (2000) Positive modulation of AMPA receptoin rs creases neutrophin expression by hippocampal and cortical neurons. J Neurosci 20:8-21
16. Sommer B, Keinänen K, Verdoorn TA, Wisden W, Burnashev N, Herb A, Köhler M, Takagi T, Sakmann B, Seeburg PH (1990) Flip and flop: a cell-specific functional switch in glutamate- operated channels of the CNS. Science 249:1580-1585
17. Quirk JC, Siuda ER, Nisenbaum ES (2004) Molecular determinants responsible for differences in desensitization kinetics of AMPA receptor splice variants. J Neurosci 24:11416-11420
18. Armstrong N, Sun Y, Chen GQ, Gouaux E (1998) Structure of a glutamate-receptor ligandbinding core in complex with kainate. Nature 395:913-917
19. Armstrong N, Gouaux E (2000) Mechanisms for activation and antagonism of an AMPAsensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. Neuron 28:165-181
20. Sun Y, Olson R, Horning M, Armstrong N, Mayer M, Gouaux E (2002) Mechanism of glutamate receptor desensitization. Nature 417:245-253
21. Esteban JA (2003) AMPA receptor trafficking: a road map for synaptic plasticity. Mol Interv 3:375-385
22. Bredt DS, Nicoll RA (2003) AMPA receptor trafficking at excitatory synapses. Neuron 40:361-379
23. Kato AS, Siuda ER, Nisenbaum ES, Bredt DS (2008) AMPA receptor subunit-specific regulation by a distinct family of type II TARPs. Neuron 59:986-996
24. Tomita S, Chen L, Kawasaki Y, Petralia RS, Wenthold RJ, Nicoll RA, Bredt DS (2003) Functional studies and distribution define a family of transmembrane AMPA receptor regulatory proteins. J Cell Biol 161:805-816
25. Milstein A, Zhou W, Karimzadegan S, Bredt D, Nicoll R (2007) TARP subtypes differentially and dose-dependently control synaptic AMPA receptor gating. Neuron 55:905-918
26. Martinez-Turrillas R, Frechilla D, Del Rio J (2002) Chronic antidepressant treatment increases the membrane expression of AMPA receptors in rat hippocampus. Neuropharmacology 43:1230-1237
27. Martínez-Turrillas R, Del Río J, Frechilla D (2005) Sequential changes in BDNF mRNA expression and synaptic levels of AMPA receptor subunits in rat hippocampus after chronic antidepressant treatment. Neuropharmacology 49:1178-1188
28. Ito I, Tanabe S, Kohda A, Sugiyama H (1990) Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J Physiol 424:533-543
29. Partin KM, Fleck MW, Mayer ML (1996) AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate. J Neurosci 16:6634-6647
30. Miu P, Jarvie KR, Radhakrishnan V, Gates MR, Ogden A, Ornstein PL (2001) Novel AMPA receptor potentiators LY392098 and LY404187: effects on recombinant human AMPA receptors in vitro. Neuropharmacology 40:976-983
31. Quirk JC, Nisenbaum ES (2002) LY404187: a novel positive allosteric modulator of AMPA receptors. CNS Drug Rev 8:255-282
32. Partin KM, Patneau DK, Mayer ML (1994) Cyclothiazide differentially modulates desensitization of AMPA receptor splice variants. Mol Pharmacol 46:129-138
33. Arai A, Lynch G (1998) AMPA receptor desensitization modulates synaptic responses induced by repetitive afferent stimulation in hippocampal slices. Brain Res 799:235-242
34. Arai A, Lynch G (1998) The waveform of synaptic transmission at hippocampal synapses is not determined by AMPA receptor desensitization. Brain Res 799:230-234
35. O'Neill MJ, Murray TK, Clay MP, Lindstrom T, Yang CR, Nisenbaum ES (2005) LY503430: pharmacology, pharmacokinetics, and effects in rodent models of Parkinson's disease. CNS Drug Rev 11:77-96
36. Sekiguchi M, Fleck MW, Mayer ML, Takeo J, Chiba Y, Yamashita S et al (1997) A novel allosteric potentiator of AMPA receptors: 4-[2-(phenylsulfonylamino)ethylthio]-2, 6- difluoro-phenoxyacetamide. J Neurosci 17:5760-5771
37. Tomita S, Sekiguchi M, Wada K, Nicoll RA, Bredt DS (2006) Stargazin controls the pharmacology of AMPA receptor potentiators. Proc Natl Acad Sci USA 103:10064-10067
38. Montgomery KE, Kessler M, Arai AC (2009) Modulation of agonist binding to AMPA receptors by 1-(1, 4-benzodioxan-6-ylcarbonyl)piperidine (CX546): differential effects across brain regions and GluA1-4/transmembrane AMPA receptor regulatory protein combinations. J Pharmacol Exp Ther 331:965-974
39. Castrén E, Rantamäki T (2010) Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment. CNS Drugs 24:1-7
40. Chao MV (2003) Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci 4:299-309
41. Schlessinger J, Ullrich A (1992) Growth factor signaling by receptor tyrosine kinases. Neuron 9:383-391
42. Allendoerfer KL, Cabelli RJ, Escandon E, Kaplan DR, Nikolics K, Shatz CJ (1994) Regulation of neurotrophin receptors during the maturation of the mammalian visual system. J Neurosci 14:1795-1811
43. Middlemas DS, Lindberg RA, Hunter T (1991) TrkB, a neural receptor protein-tyrosine kinase: evidence for a full-length and two truncated receptors. Mol Cell Biol 11:143-153
44. Wang JW, Dranovsky A, Hen R (2008) The when and where of BDNF and the antidepressant response. Biol Psychiatry 63:640-641
45. Frim DM, Uhler TA, Galpern WR, Beal MF, Breakefield XO, Isacson O (1994) Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat. Proc Natl Acad Sci USA 91:5104-5108
46. Mamounas LA, Blue ME, Siuciack JA, Altar CA (1995) Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J Neurosci 15: 7929-7939
47. Mamounas LA, Altar CA, Blue ME, Kaplan DR, Tessarollo L, Lyons WE (2000) BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci 20:771-782
48. Santarelli L, Saxe M, Gross C, Surget A, Battaglia F, Dulawa S et al (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301:805-809
49. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C et al (2003) Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54:70-75
50. Nibuya M, Morinobu S, Duman RS (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 15:7539-7547
51. Nibuya M, Nestler EJ, Duman RS (1996) Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J Neurosci 16:2365-2372
52. Fujimaki K, Morinobu S, Duman RS (2000) Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus. Neuropsychopharmacology 22:42-51
53. Neeper SA, Gómez-Pinilla F, Choi J, Cotman CW (1995) Exercise and brain neurotrophins. Nature 373:109
54. Neeper SA, Gómez-Pinilla F, Choi J, Cotman CW (1996) Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Res 726:49-56
55. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22:3251-3261
56. Saarelainen T, Hendolin P, Lucas G, Koponen E, Sairanen M, MacDonald E et al (2003) Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci 23:349-357
57. Legutko B, Li X, Skolnick P (2001) Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator. Neuropharmacology 40:1019-1027
58. Mackowiak M, O'Neill M, Hicks C, Bleakman D, Skolnick P (2002) An AMPA receptor potentiator modulates hippocampal expression of BDNF: An in vivo study. Neuropharmacology 43:1-10
59. Bai F, Bergeron M, Nelson DL (2003) Chronic AMPA receptor potentiator (LY451646) treatment increases cell proliferation in adult rat hippocampus. Neuropharmacology 44:1013-1021
60. Su XW, Li XY, Banasr M, Koo JW, Shahid M, Henry B, Duman RS (2009) Chronic treatment with AMPA receptor potentiator Org 26576 increases neuronal cell proliferation and survival in adult rodent hippocampus. Psychopharmacol (Berl) 206:215-222
61. Li X, Witkin JM, Need AB, Skolnick P (2003) Enhancement of antidepressant potency by a potentiator of AMPA receptors. Cell Mol Neurobiol 23:419-430
62. Li X, Tizzano JP, Griffey K, Clay M, Lindstrom T, Skolnick P (2001) Antidepressant-like actions of an AMPA receptor potentiator (LY392098). Neuropharmacology 40:1028-1033
63. Farley S, Apazoglou K, Witkin JM, Giros B, Tzavara ET (2010) Antidepressant-like effects of an AMPA receptor potentiator under a chronic mild stress paradigm. Int J Neuropsychopharmacol 11:1-12
64. Bai F, Li X, Clay M, Lindstrom T, Skolnick P (2001) Intra- and interstrain differences in models of "behavioral despair". Pharmacol Biochem Behav 70:187-192
65. Knapp RJ, Goldenberg R, Shock C, Cecil A, Watkins J, Miller C et al (2002) Antidepressant activity of memory-enhancing drugs in the reduction of submissive behavior model. Eur J Pharmacol 440:27-35
66. Szewczyk B, Poleszak E, Sowa-Kućma M, Wróbel A, Slotwiński S, Listos J, Wlaź P, Cichy A, Siwek A, Dybala M, Golembiowska K, Pilc A, Nowak G (2009) The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test. Amino Acids [Epub ahead of print]
67. Duman RS, Heninger GR, Nestler EJ (1997) A molecular and cellular theory of depression. Arch Gen Psychiatry 54:597-606
68. Conti AC, Cryan JF, Dalvi A, Lucki I, Blendy JA (2002) cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. J Neurosci 22:3262-3268
69. Miró X, Pérez-Torres S, Artigas F, Puigdomènech P, Palacios JM, Mengod G (2002) Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study. Neuropharmacology 43:1148-1157
70. Hayashi T, Umemori H, Mishina M, Yamamoto T (1999) The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn. Nature 397:72-76
71. Freed WJ, Dillon-Carter O, Kleinman JE (1993) Properties of [3H]AMPA binding in postmortem human brain from psychotic subjects and controls: increases in caudate nucleus associated with suicide. Exp Neurol 121:48-56
72. Noga JT, Hyde TM, Herman MM, Spurney CF, Bigelow LB, Weinberger DR et al (1997) Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains. Synapse 27:168-176
73. de Kloet ER, Joels M, Holsboer F (2005) Stress and the brain: from adaptation to disease. Nat Rev Neurosci 6:463-475
74. Shors TJ, Thompson RF (1992) Acute stress impairs (or induces) synaptic long-term potentiation (LTP) but does not affect paired-pulse facilitation in the stratum radiatum of rat hippocampus. Synapse 11:262-265
75. Tocco G, Shors TJ, Baudry M, Thompson RF (1991) Selective increase of AMPA binding to the AMPA/quisqualate receptor in the hippocampus in response to acute stress. Brain Res 559:168-171
76. Karst H, Joels M (2003) Effect of chronic stress on synaptic currents in rat hippocampal dentate gyrus neurons. J Neurophysiol 89:625-633
77. Krugers HJ, Koolhaas JM, Bohus B, Korf J (1993) A single social stress-experience alters glutamate receptor-binding in rat hippocampal CA3 area. Neurosci Lett 154:73-77
78. Bartanusz V, Aubry JM, Pagliusi S, Jezova D, Baffi J, Kiss JZ (1995) Stress-induced changes in messenger RNA levels of N-methyl-D-aspartate and AMPA receptor subunits in selected regions of the rat hippocampus and hypothalamus. Neuroscience 66:247-252
79. Schwendt M, Jezova D (2000) Gene expression of two glutamate receptor subunits in response to repeated stress exposure in rat hippocampus. Cell Mol Neurobiol 20:319-329
80. Rosa ML, Guimaraes FS, Pearson RC, Del Bel EA (2002) Effects of single or repeated restraint stress on GluR1 and GluR2 flip and flop mRNA expression in the hippocampal formation. Brain Res Bull 59:117-124
81. Suenaga T, Morinobu S, Kawano K, Sawada T, Yamawaki S (2004) Influence of immobilization stress on the levels of CaMKII and phospho-CaMKII in the rat hippocampus. Int J Neuropsychopharmacol 7:299-309
82. Du J, Gray NA, Falke CA, Chen W, Yuan P, Szabo ST et al (2004) Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression. J Neurosci 24:6578-6589
83. Naylor P, Stewart CA, Wright SR, Pearson RC, Reid IC (1996) Repeated ECS induces GluR1 mRNA but not NMDAR1A-G mRNA in the rat hippocampus. Brain Res Mol Brain Res 35:349-353
84. Svenningsson P, Tzavara ET, Witkin JM, Fienberg AA, Nomikos GG, Greengard P (2002) Involvement of striatal and extrastriatal DARPP-32 in biochemical and behavioral effects of fluoxetine (Prozac). Proc Nat Acad Sci USA 99:3182-3187
85. Svenningsson P, Bateup H, Qi H, Takamiya K, Huganir RL, Spedding M, Roth BL, McEwen BS, Greengard P (2007) Involvement of AMPA receptor phosphorylation in antidepressant actions with special reference to tianeptine. Eur J Neurosci 26:3509-3517
86. Du J, Suzuki K, Wei Y, Wang Y, Blumenthal R, Chen Z, Falke C, Zarate CA Jr, Manji HK (2007) The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders. Neuropsychopharmacology 32:793-802
87. Roche KW, O'Brien RJ, Mammen AL, Bernhardt J, Huganir RL (1996) Characterization of multiple phosphorylation sites on the AMPA receptor GluR1 subunit. Neuron 16:1179-1188
88. Barria A, Muller D, Derkach V, Griffith LC, Soderling TR (1997) Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. Science 276:2042-2045
89. Lee HK, Barbarosie M, Kameyama K, Bear MF, Huganir RL (2000) Regulation of distinct AMPA receptor phosphorylation sites during bidirectional synaptic plasticity. Nature 405:955-959
90. Du J, Gray NA, Falke C, Yuan P, Szabo S, Manji HK (2003) Structurally dissimilar antimanic agents modulate synaptic plasticity by regulating AMPA glutamate receptor subunit GluR1 synaptic expression. Ann N Y Acad Sci 1003:378-380
91. Brennan BP, Hudson JI, Jensen JE, McCarthy J, Roberts JL, Prescot AP, Cohen BM, Pope HG Jr, Renshaw PF, Ongür D (2010) Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology 35:834-846
92. Zarate CA Jr, Manji HK (2008) The role of AMPA receptor modulation in the treatment of neuropsychiatric diseases. Exp Neurol 211:7-10
93. Karasawa J, Shimazaki T, Kawashima N, Chaki S (2005) AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist. Brain Res 1042:92-98
94. Maeng S, Zarate CA Jr, Du J, Schloesser RJ, McCammon J, Chen G, Manji HK (2008) Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 63:349-352
95. Dybala M, Siwek A, Poleszak E, Pilc A, Nowak G (2008) Lack of NMDA-AMPA interaction in antidepressant-like effect of CGP 37849, an antagonist of NMDA receptor, in the forced swim test. J Neural Transm 115:1519-1520
96. Gould TD, O'Donnell KC, Dow ER, Du J, Chen G, Manji HK (2007) Involvement of AMPA receptors in the antidepressant-like effects of lithium in the mouse tail suspension test and forced swim test. Neuropharmacology 54:577-587